June 23/30, 2020, Vol 323, No. 24, Pages 2445-2536
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)An Unprecedented Partnership for Unprecedented Times
Francis S. Collins, MD, PhD; Paul Stoffels, MD
free access has active quiz has multimedia has audio
JAMA. 2020;323(24):2455-2457. doi:10.1001/jama.2020.8920
This Viewpoint describes how the National Institutes of Health is partnering with more than a dozen biopharmaceutical companies and multiple other agencies to develop an international strategy for a coordinated research response to the COVID-19 pandemic, including prioritizing vaccine and drug candidates.
Audio Interview: The NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative